Who
Lon Cardon
Director
Company insider
Files Form 4 as: Director, Mirum Pharmaceuticals; Director, OnKure Therapeutics.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 8 Apr 2021
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,703 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,268 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,977 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —5,703 | filing |
| 5 Jun 2024filed 7 Jun 2024 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,779 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,703 at $0.00 | filing |
| 12 Jun 2023filed 14 Jun 2023 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,083 at $0.00 | filing |
| 19 Dec 2022filed 19 Dec 2022 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 8 Apr 2021filed 12 Apr 2021 | OKUR OnKure Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.